HomeDilutionPromotionUplist RadarBuzzToday on EDGARDead Stock Check
PubCo Insight › Tickers › NTLA

$NTLANASDAQ NMS - GLOBAL MARKET

Intellia Therapeutics, Inc.
Biotechnology
Market Cap
$1.84B
Exchange
NASDAQ NMS - GLOBAL MARKET
Filings (365d)
40
News (14d)
2
CIK
0001652130
Website
Company site ↗
SEC Filing Timeline
10-QAug 06, 2026
Quarterly report
8-KAug 06, 2026
Earnings release · Items 2.02,9.01
8-KJun 15, 2026
Reg FD disclosure · Items 7.01,8.01,9.01
8-KJun 10, 2026
Shareholder vote results · Items 5.07
10-QMay 11, 2026
Quarterly report
8-KMay 11, 2026
Earnings release · Items 2.02,9.01
8-KApr 30, 2026
Material agreement · Items 1.01,2.02,9.01
DEFA14AApr 30, 2026
Additional proxy
DEF 14AApr 30, 2026
Proxy statement
424B5Apr 29, 2026
Prospectus / offering
424B5Apr 27, 2026
Prospectus / offering
8-KApr 27, 2026
Reg FD disclosure · Items 7.01,8.01,9.01
8-KApr 10, 2026
Charter/bylaws amendment · Items 5.03,9.01
424B5Mar 02, 2026
Prospectus / offering
8-KMar 02, 2026
Material agreement · Items 1.01,7.01,8.01,9.01
Recent News (Finnhub)
Citizens Reiterates Market Outperform on Intellia Therapeutics, Maintains $30 Price Target
Benzinga · Aug 25
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q2 2026 Update
SeekingAlpha · Aug 19
Source-linked from SEC EDGAR + Finnhub aggregated news.
Not investment advice. Always verify on SEC.gov directly.
PubCo Insight

See the dilution and promotion flags before you see the pitch.

Each week: the micro and small-caps now showing dilution or paid-promotion signals, with the SEC filing behind every flag. No recommendations, no price targets.

Every flag links to its EDGAR filing so you can check it yourself. Sponsored coverage disclosed under SEC 17(b). One-click unsubscribe.